Browse grants

Health Resources and Services Administration · $1M–$1.6M

This HRSA Medical Student Education program funds public medical schools in states with projected primary care provider shortages to expand education for future physicians. Eligibility is narrow: only accredited public medical schools in a small set of identified shortage states, and schools currently receiving MSE funding are excluded. Awards range from about $1,000,000 to $1,625,000. Most organizations and individuals are not eligible.

National Institutes of Health · Amount varies

This NIH R01 funds research into the cellular, molecular, and circuit-level biology underlying complex brain disorders, supporting hypothesis-generating or hypothesis-testing studies using model organisms or human cell-based assays. It's intended for researchers with feasibility or proof-of-concept already established (early-stage exploratory work should apply to a companion R21 instead). Eligible U.S. institutions include HBCUs and tribal colleges; the deadline is September 7, 2026.

National Institutes of Health · Amount varies

This NIH P41 opportunity funds Biomedical Technology Resource Centers that develop new research technologies, train other researchers in their use, and share them broadly with the scientific community. It's aimed at eligible U.S. research institutions (HBCUs and tribal colleges included); foreign organizations are not eligible. The deadline is September 7, 2026.

National Institutes of Health · Amount varies

This NIH (NIAAA) R34 award supports planning and pilot health services research aimed at closing the treatment gap for alcohol use disorder. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here, though R34 grants are typically smaller, planning-stage awards. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R01 award funds translational research on schizophrenia and related disorders in mid- to late-life, aiming to clarify illness trajectory and identify prevention and treatment targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Up to $500K

This NIH (NIAAA) R01 award funds health services research aimed at closing the treatment gap for alcohol use disorder, including improving access to and appeal of treatment and reducing disparities. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. The stated maximum award is about $500,000. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH (NIAAA) R34 award supports planning and pilot research on alcohol use disorder treatment and recovery; a clinical trial is required. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here, though R34 grants are typically smaller, planning-stage awards. Applications are submitted through eligible organizations.

National Institutes of Health · Amount varies

This NIH R01 award funds research into the mechanisms behind neuropsychiatric symptoms in Alzheimer's disease and related dementias, with the goal of identifying novel therapeutic targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R21 award funds exploratory research into the mechanisms behind neuropsychiatric symptoms in Alzheimer's disease and related dementias, with the aim of revealing novel therapeutic targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R36 award funds up to two years of doctoral dissertation research on substance use and substance use disorders, aligned with NIDA funding priorities, aimed at doctoral candidates across academic disciplines. Eligible U.S. institutions include HBCUs, tribal colleges, and minority-serving institutions; foreign organizations are not eligible. The deadline is September 7, 2026.

National Institutes of Health · Amount varies

This NIH/National Cancer Institute R01 award supports assay development and screening to discover small-molecule chemical probes, drugs, or immunomodulators, with no clinical trials allowed. It is aimed at research institutions and investigators conducting early-stage discovery research, and lists a broad set of eligible U.S. organization types. Funding amounts are not specified here. Applications are submitted through eligible organizations.

National Institutes of Health · Amount varies

This NIH R21 award funds exploratory translational research on schizophrenia and related disorders in mid- to late-life, aiming to understand illness trajectory and identify prevention and treatment targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations.

National Institutes of Health · Up to $499K

This NIH/National Cancer Institute R01 award funds projects to improve the reliability and translational usefulness of mammalian cancer and tumor models, with no clinical trials allowed. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. The stated maximum award is about $499,000. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R21 award supports early-stage, high-risk exploratory research into the cellular, molecular, and circuit biology of risk factors for complex brain disorders, with no clinical trials allowed. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R01 award funds research on how social isolation and loneliness raise suicide risk in older adults, including mechanism studies and intervention development and testing. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Up to $500K

This NIH (NIAAA) R01 award funds treatment, pharmacotherapy, and recovery research for alcohol use disorder, including medications development, behavioral therapies, and recovery science; a clinical trial is required. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. The stated maximum award is about $500,000. Applications are submitted through eligible organizations.

National Institutes of Health · Amount varies

This NIH R21 funds research into how social isolation and loneliness affect suicide risk in older adults, including studies on neurobiological and environmental mechanisms, intervention testing, and service-delivery models. It's open to eligible U.S. research institutions (HBCUs and tribal colleges included). The deadline is September 7, 2026.

National Institutes of Health · Amount varies

This NIH/National Cancer Institute award funds NCORP Research Bases that serve as research hubs designing and running multi-institution cancer control, prevention, and care-delivery clinical trials. It is aimed at established research organizations with the scientific, statistical, and data-management infrastructure to lead a community oncology research network. Foreign organizations and foreign components of U.S. organizations are not eligible. Eligibility details are in the NOFO, so review Section III before applying.

National Institutes of Health · Amount varies

This NIH/NCI program (UG1) funds NCORP Academic Community Sites, which are consortia led by an academic center with affiliated community hospitals and oncology practices, to broaden participation in cancer control, prevention, treatment, and care-delivery studies. Eligibility centers on academic medical centers with the infrastructure to support accrual across affiliates; foreign organizations and foreign components are not eligible. No award amount is stated. This is restricted to qualifying academic-led community research consortia, not general applicants.

National Institutes of Health · Amount varies

This NIH/NCI program (UG1) funds NCORP Community Sites, which are healthcare systems or consortia of community hospitals, oncology practices, public hospitals, or health centers that broaden participation in cancer control, prevention, treatment, and care-delivery research. Eligibility centers on healthcare systems and community-based oncology networks; foreign organizations and foreign components are not eligible. No award amount is stated. This is aimed at community healthcare organizations participating in NCORP, not individuals or general nonprofits.